Vascular Solutions Inc. (NASDAQ:VASC) saw unusually-strong trading volume on Thursday . Approximately 169,831 shares were traded during trading, an increase of 22% from the previous session’s volume of 139,331 shares.The stock last traded at $47.07 and had previously closed at $47.34.

A number of analysts have recently issued reports on VASC shares. Piper Jaffray Cos. reaffirmed a “buy” rating and set a $44.00 target price on shares of Vascular Solutions in a research report on Thursday, April 21st. Zacks Investment Research raised Vascular Solutions from a “hold” rating to a “buy” rating and set a $39.00 target price on the stock in a research report on Thursday, April 28th. Sidoti lowered Vascular Solutions from a “buy” rating to a “neutral” rating and set a $47.00 target price on the stock. in a research report on Tuesday, July 12th. TheStreet raised Vascular Solutions from a “hold” rating to a “buy” rating in a research report on Monday, July 25th. Finally, Canaccord Genuity reaffirmed a “buy” rating on shares of Vascular Solutions in a research report on Wednesday. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $47.38.

The stock has a market capitalization of $825.23 million and a PE ratio of 87.37. The firm’s 50 day moving average is $43.78 and its 200 day moving average is $35.92.

Vascular Solutions (NASDAQ:VASC) last posted its quarterly earnings results on Monday, July 25th. The medical device company reported $0.33 EPS for the quarter, beating the consensus estimate of $0.30 by $0.03. The company had revenue of $41.20 million for the quarter, compared to analysts’ expectations of $41.40 million. The company’s revenue was up 9.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.29 earnings per share. On average, equities research analysts anticipate that Vascular Solutions Inc. will post $1.24 EPS for the current year.

In related news, CEO Howard Root sold 34,418 shares of the company’s stock in a transaction on Tuesday, May 24th. The shares were sold at an average price of $39.05, for a total value of $1,344,022.90. Following the completion of the sale, the chief executive officer now directly owns 348,340 shares in the company, valued at $13,602,677. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP William Rutstein sold 10,011 shares of the company’s stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $46.26, for a total transaction of $463,108.86. The disclosure for this sale can be found here.

An institutional investor recently raised its position in Vascular Solutions stock. Argent Capital Management LLC raised its position in Vascular Solutions Inc. (NASDAQ:VASC) by 117.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 97,035 shares of the medical device company’s stock after buying an additional 52,400 shares during the period. Argent Capital Management LLC owned approximately 0.56% of Vascular Solutions worth $3,337,000 at the end of the most recent reporting period.

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.